Helen X Chen
-
- Cancer Immunotherapy and Biomarkers 2
- Lung Cancer Research Studies 2
-
- Cancer Mechanisms and Therapy 2
-
- Lung Cancer Treatments and Mutations 2
-
- Melanoma and MAPK Pathways 2
- DNA and Nucleic Acid Chemistry 1
-
- Synthesis and biological activity 1
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Naiyer A. RizviJohn L. MarshallR. Russell MartinElizabeth NessWilliam DahutBarry DvorchikMichael HawkinsElad Sharon
- Cited by
- OncologyHematologyOphthalmology
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)Cancer (1 paper)
- Partner nations
- United StatesMalaysiaAustria
In The Last Decade
Helen X Chen
6 papers receiving 121 citations
Peers
Comparison fields: 5 of 36
- Oncology 71
- Hematology 21
- Ophthalmology 10
- Genetics 11
- Immunology 21
Countries citing papers authored by Helen X Chen
This map shows the geographic impact of Helen X Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen X Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen X Chen more than expected).
Fields of papers citing papers by Helen X Chen
This network shows the impact of papers produced by Helen X Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen X Chen. The network helps show where Helen X Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen X Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 24 | |
| 4 | 2023 | 7 | |
| 5 | 2021 | 25 | |
| 6 | 2016 | 14 | |
| 7 | 2001 | 5 | |
| 8 | A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors. | 2000 | 52 |
About Helen X Chen
Helen X Chen is a scholar working on Oncology, Pathology and Forensic Medicine and Ophthalmology, having authored 8 papers that have together received 127 indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Treatments and Mutations (2 papers), Melanoma and MAPK Pathways (2 papers), Synthesis and biological activity (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and DNA and Nucleic Acid Chemistry (1 paper). The work is most often cited by research in Oncology (71 citations), Hematology (21 citations) and Ophthalmology (10 citations). Helen X Chen has collaborated with scholars based in United States, Malaysia and Austria. Frequent co-authors include Naiyer A. Rizvi, John L. Marshall, R. Russell Martin, Elizabeth Ness, William Dahut, Barry Dvorchik, Michael Hawkins, Elad Sharon, Howard Streicher and James H. Murray. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.